Tamoxifen Citrate API

For regulated pharmaceutical and institutional B2B sourcing projects, with support for specification review, documentation planning, and export-ready bulk supply.

Suitable for buyers evaluating tamoxifen citrate API for regulated pharmaceutical and institutional sourcing projects, with review typically focused on identity, assay basis, document scope, packaging integrity, and destination-market compliance requirements.

  • Tamoxifen citrate API for regulated pharmaceutical and institutional sourcing projects
  • Specification, batch-document, and destination-market review support available
  • COA, SDS/MSDS, and TDS/specification sheet can be arranged on request
  • Bulk packing and export supply coordination for qualified B2B projects

Tell us your application, target specification, and destination market so we can support grade selection, documentation review, and packaging recommendations.

Tamoxifen Citrate API

Quick Specs

Identity

INCI Name

Tamoxifen Citrate

Alias

Tamoxifen citrate; Tamoxifen citrate API; Nolvadex active ingredient (reference only); SERM active ingredient

CAS Number

54965-24-1

Molecular Formula

C32H37NO8

Molecular Weight

563.64

Quality

Assay

98.0% min

Grade

Pharm Grade

Standards

BP, USP, EP

Assay Method

HPLC

Handling

Appearance

White to off-white crystalline powder / per agreed specification

Form

Powder

Solubility

Practically insoluble in water; solubility and handling behavior in the intended pharmaceutical system should be confirmed during internal development and sample review

Applications

Pharmaceutical development review, institutional procurement review, and regulated-market tamoxifen citrate API sourcing projects only

Commercial Terms

MOQ

MOQ depends on packaging and specification.

Lead Time

3–7 working days for standard items; bulk orders by schedule.

Incoterms

EXW / FOB / CIF / DAP / DDP

Sample

Free sample (shipping charged)

Quality & Documents
COA (per batch) • SDS/MSDS • TDS/Spec sheet (on request). Additional statements depend on product and market.

Product Overview

Tamoxifen citrate is a regulated pharmaceutical ingredient commonly reviewed for qualified B2B and institutional sourcing projects.

It is usually supplied as a white to off-white powder under an agreed API specification, and buyers often review salt identity, assay basis, document scope, and destination-market requirements before technical or commercial evaluation.

It is generally discussed for pharmaceutical development review, institutional procurement, and regulated-market API sourcing workflows, with sample support and bulk-supply documentation available for qualified evaluation.

Tamoxifen Citrate powder

Applications

Pharmaceutical Development Review
Reviewed for regulated pharmaceutical projects where buyers need tamoxifen citrate API with defined identity, assay basis, and batch-document support before internal evaluation.

Institutional Procurement Review
Can be considered for qualified institutional and regulated-market sourcing workflows where specification alignment, documentation scope, and packaging compliance are part of the procurement process.

Regulated Market API Sourcing
Also discussed for destination markets that require formal review of specification basis, document pack, handling conditions, and supply-chain communication before commercial release.

How to Choose the Right Grade / Form

For regulated-market review
Confirm whether the project should follow USP, EP, BP, IP, or another agreed technical basis before supplier comparison.

For internal quality review
Check not only assay, but also identity basis, impurity scope, packaging integrity, and document completeness.

For destination-market supply
Confirm the required document pack, label format, shipment arrangement, and compliance expectation before quotation and release planning.

Before ordering, confirm
Target market; intended dosage-form route; specification basis; required test items; packaging format; document pack; compliance-review pathway.

Technical & Formulation Notes

Technical Notes

Technical review should focus on tamoxifen citrate identity, assay basis, impurity-control scope, packaging integrity, and suitability for the intended regulated pharmaceutical workflow.

Before evaluation, buyers are advised to confirm destination market, dosage-form route, required specification basis, quality-review scope, and document pack.

Commercial supply typically involves controlled pharmaceutical-ingredient production with in-process QC and batch release against the agreed specification basis.

Final release is usually based on agreed items such as appearance, identification, assay, related-substances scope, packaging integrity, and batch-document consistency.

Tamoxifen citrate should be evaluated only within the relevant regulated pharmaceutical development or institutional review system rather than as a general-purpose ingredient claim.

For project review, buyers usually confirm identity basis, assay method, impurity-control scope, handling and storage requirements, and documentation fit during internal technical and quality evaluation.

Final suitability should be validated through internal review according to the intended market, dosage-form route, regulatory pathway, and quality requirements.

- Appearance
- Identification
- Assay
- Related substances / impurity scope, if required
- Loss on drying or moisture-related control, if required
- Packaging integrity
- Batch traceability linked to COA

Product specifications

TestSpecificationMethod
AppearanceWhite to off-white crystalline powder / per specVisual
IdentificationConformsPer agreed specification
Assay98.0% min / per agreed specHPLC / per spec
CAS No.54965-24-1Reference
Molecular FormulaC32H37NO8Reference
Molecular Weight563.64Reference
DocumentsCOA per batch; SDS/MSDS and TDS/spec sheet on requestReference

Storage, Shelf Life & Packaging

Storage

Store in a cool, dry, and well-closed condition away from moisture, direct heat, and strong light.

Keep the package tightly sealed after opening and handle according to the applicable pharmaceutical-material storage and quality-control requirements.

Shelf Life

Shelf life should be confirmed according to the specific batch, specification basis, storage condition, and packaging format.

Please refer to the COA, product label, or agreed specification sheet for the declared shelf-life period of the supplied lot.

Packaging & Logistics

Sample Packing
1 x 1 kg foil bag or small evaluation pack can be arranged for qualified technical review; shipping charged.

Mid-Size Packing
5 kg or 10 kg packing can be discussed according to project plan and destination-market requirements.

Bulk Packing
Normally 25 kg/drum according to order volume, grade confirmation, and shipment arrangement.

Customization
Custom packaging, label details, and shipping-mark discussion can be arranged according to regulated-market and institutional project needs.

Logistics & Documents
Packing configuration and document pack should be aligned before shipment to support storage, handling, and destination-market compliance review.

lw_packaging_cartons_drums_

Supply, Documentation & Customization

Documents & Compliance

COA, SDS/MSDS, and TDS/spec sheet available based on product and market requirements.

Customization & Private Label

Custom packing, private label, and labeling support available depending on product type and order scope.

Commercial Support

Sample, lead time, and incoterm options can be discussed according to destination market and supply plan.

Why Source From Lifeworth

Specification-led sourcing communication
Support for buyers who need tamoxifen citrate sourcing aligned with assay basis, technical documentation, and destination-market review.

Regulated project positioning
The product page and sourcing discussion should stay centered on pharmaceutical and institutional B2B requirements rather than consumer-oriented claims.

Batch documentation support
COA per lot with SDS/MSDS and TDS available for technical, quality, and purchasing review.

Export-ready bulk coordination
Packaging, labeling, and shipment planning can be arranged for qualified international pharmaceutical ingredient sourcing projects.

Lifeworth Company Profile

FAQ

1) What is tamoxifen citrate mainly reviewed for on this page?
It is presented as a regulated pharmaceutical ingredient for qualified B2B and institutional sourcing review, not as a consumer-facing finished product.

2) Is this a general nutraceutical or supplement ingredient?
No. This page is intended for regulated pharmaceutical and institutional API sourcing projects only.

3) What should buyers confirm before ordering?
Please confirm destination market, dosage-form route, specification basis, quality-review scope, packaging requirement, and document pack before scale-up.

4) What documents are available?
COA per batch / lot is available. SDS/MSDS and TDS/specification sheet can be provided on request. Additional compliance documents depend on project scope.

5) Is sample evaluation available?
Yes. Small sample packing can usually be arranged for qualified technical review and sourcing evaluation.

6) Is this page intended for direct patient purchase or treatment guidance?
No. The content is structured for regulated B2B ingredient communication and should not replace project-specific regulatory, medical, or legal review.

Need more answers?

Explore our full FAQ library for documentation, compliance, shipping, and ordering guidelines.

Request a Sample or Quote